Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

Дата публикации: 18-06-2026 00:00:00

This nonrandomized clinical trial evaluates the efficacy and tolerance of single-fraction stereotactic body radiotherapy in men with localized prostate cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer	0	7	25-06-2026
2	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
3	Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy	0	7	18-06-2026
4	Survival in the SONIA Trial	0	8	18-06-2026
5	Survival in the SONIA Trial	0	7	18-06-2026
6	Less Can Be More by Circulating Tumor DNA Use in ERBB2 -Positive Breast Cancer	0	7	25-06-2026
7	Team finds way to reverse ovarian cancer’s chemo resistance	5	8	25-06-2026
8	Error in Open Access License	0	5	18-06-2026
9	Survival in the SONIA Trial—Reply	0	5	18-06-2026
10	Peripapillary Unilateral Retinal Pigment Epithelium Dysgenesis	0	5	25-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: jamanetwork.com.